SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-210731
Filing Date
2023-08-11
Accepted
2023-08-11 16:12:58
Documents
15
Period of Report
2023-08-11
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d539294d8k.htm   iXBRL 8-K 34648
2 EX-3.1 d539294dex31.htm EX-3.1 8462
3 EX-99.1 d539294dex991.htm EX-99.1 8099
7 GRAPHIC g539294g0810005732497.jpg GRAPHIC 3989
  Complete submission text file 0001193125-23-210731.txt   191696

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mtem-20230811.xsd EX-101.SCH 2878
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mtem-20230811_lab.xml EX-101.LAB 18740
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mtem-20230811_pre.xml EX-101.PRE 11726
9 EXTRACTED XBRL INSTANCE DOCUMENT d539294d8k_htm.xml XML 3608
Mailing Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729
Business Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729 512 896 1555
Molecular Templates, Inc. (Filer) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32979 | Film No.: 231164230
SIC: 2834 Pharmaceutical Preparations